Avalo Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Avalo Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Avalo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $471K, a 47.3% decline year-over-year.
  • Avalo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.83M, a 14.9% decline year-over-year.
  • Avalo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.48M, a 54% decline from 2022.
  • Avalo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.55M, a 7.56% decline from 2021.
  • Avalo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.17M, a 20.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.48M -$4.08M -54% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $7.55M -$618K -7.56% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $8.17M +$1.39M +20.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $6.79M +$4.32M +176% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $2.46M +$31.7K +1.31% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $2.43M +$1.27M +110% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $1.16M -$538K -31.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $1.69M +$1.3M +329% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $395K -$692K -63.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $1.09M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.